⌘K
Loading ticker…
Benitec Biopharma Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Benitec Biopharma Inc. Common Stock (BNTC) has a 3-month relative strength percentile of 64 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 49. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 7.0%, relative volume 9.84×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
64 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
BNTC is held by 4 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $7M notional. Top 3 carry $14M.
Top 4 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $7M |
| IWMiShares Russell 2000 ETF | 0.01% | $5M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| IWOiShares Russell 2000 Growth ETF | 0.01% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BNTC Jan avg: 0.92% median: -9.30% win: 25% σ: 22.98% n: 4 2022-04-12 → 2026-05-29 | BNTC Feb avg: 25.79% median: 20.53% win: 75% σ: 35.40% n: 4 2022-04-12 → 2026-05-29 | BNTC Mar avg: -5.43% median: 0.03% win: 50% σ: 16.96% n: 4 2022-04-12 → 2026-05-29 | BNTC Apr avg: 9.87% median: 4.46% win: 60% σ: 31.87% n: 5 2022-04-12 → 2026-05-29 | BNTC May avg: -2.12% median: -4.07% win: 40% σ: 19.68% n: 5 2022-04-12 → 2026-05-29 | BNTC Jun avg: -5.76% median: -4.85% win: 25% σ: 14.38% n: 4 2022-04-12 → 2026-05-29 (current) | BNTC Jul avg: -7.45% median: -14.54% win: 25% σ: 21.98% n: 4 2022-04-12 → 2026-05-29 | BNTC Aug avg: 1.61% median: 1.52% win: 50% σ: 16.54% n: 4 2022-04-12 → 2026-05-29 | BNTC Sep avg: -10.49% median: 0.92% win: 50% σ: 26.31% n: 4 2022-04-12 → 2026-05-29 | BNTC Oct avg: -0.60% median: 15.48% win: 75% σ: 34.89% n: 4 2022-04-12 → 2026-05-29 | BNTC Nov avg: -4.94% median: -7.95% win: 25% σ: 16.12% n: 4 2022-04-12 → 2026-05-29 | BNTC Dec avg: 3.40% median: 2.75% win: 75% σ: 17.29% n: 4 2022-04-12 → 2026-05-29 |